ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,518Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 98

$501K Total Retail Price of All Prescriptions

Rank: 27 out of 98

373 Patients Receiving at Least One Drug in Part D
98%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

23% of this provider’s 373 patients filled at least one prescription for a schedule two drug, compared to an average of 10%.

Schedule Three
Controlled Substances

8% of this provider’s 373 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

0% of this provider’s 13,246 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$37 was the average price of a prescription from this provider, compared to $48 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 34.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
WARFARIN SODIUM 1,152 1,070 1 1
TRAZODONE HCL 581 554 2 9
FUROSEMIDE 556 555 3 4
LEVOTHYROXINE SODIUM 511 510 4 5
LISINOPRIL 480 480 5 3
CITALOPRAM HBR 451 451 6 10
METOPROLOL TARTRATE 446 432 7 8
MIRTAZAPINE 353 353 8 11
SIMVASTATIN 302 291 9 2
AMLODIPINE BESYLATE 279 278 10 7
DONEPEZIL HCL 270 269 11 12
ATENOLOL 266 266 12 14
QUETIAPINE FUMARATE 229 229 13 23
GABAPENTIN 210 209 14 13
OMEPRAZOLE 191 191 15 6
LIDODERM 175 175 16 29
NAMENDA 172 172 17 18
PREDNISONE 168 168 18 31
OLANZAPINE 164 164 19 24
METFORMIN HCL 162 162 20 15
IPRATROPIUM-ALBUTEROL 159 159 21 45
TAMSULOSIN HCL 155 141 22 25
ATORVASTATIN CALCIUM 143 141 23 20
CARBIDOPA-LEVODOPA 134 134 24 44
HYDROCODONE-ACETAMINOPHEN 133 133 S3 25 39
POTASSIUM CHLORIDE 132 131 26 21
METOPROLOL SUCCINATE 130 129 27 16
TRAMADOL HCL 127 127 28 26
ISOSORBIDE MONONITRATE ER 122 121 29 36
RANITIDINE HCL 113 113 30 35
DIVALPROEX SODIUM 112 112 31 22
LANTUS 106 105 32 28
DIGOXIN 105 103 33 40
NYSTOP 102 99 34 64
METHADONE HCL 96 96 S2 35 126
SPIRONOLACTONE 92 92 36 71
ALLOPURINOL 91 91 37 43
FINASTERIDE 88 76 38 49
SEROQUEL 88 88 38 52
SERTRALINE HCL 86 86 40 19
DIOVAN 85 84 41 57
BUPROPION HCL 80 68 42 96
AZITHROMYCIN 76 76 43 104
LEVOFLOXACIN 71 71 44 63
CARVEDILOL 67 67 45 72
PANTOPRAZOLE SODIUM 59 58 46 42
DILTIAZEM 24HR CD 58 58 47 83
ISOSORBIDE DINITRATE 57 57 48 170
POLYETHYLENE GLYCOL 3350 56 19 49 33
NOVOLIN R 55 55 50 79
LATANOPROST 54 54 51 67
RISPERIDONE 54 54 51 27
LOSARTAN POTASSIUM 53 53 53 34
CEPHALEXIN 53 53 53 92
CIPROFLOXACIN HCL 53 53 53 86
TAMIFLU 53 53 53 134
FAMOTIDINE 50 50 57 80
COLCRYS 50 50 57 137
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 23, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.